Difference between revisions of "Retinoic Acid Derivatives"
Jump to navigation
Jump to search
m (Protected "Retinoic Acid Derivatives" ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
(→Guidance: updated to be more permissive) |
||
| Line 14: | Line 14: | ||
==Guidance== | ==Guidance== | ||
| − | Generally unacceptable if ever taken Etretinate (Tigason). | + | Generally unacceptable if ever taken Etretinate (Tigason). Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register. |
| − | + | At CT, inform the transplant centre if a donor is taking these medications, or has done so at any point in the last 12 months. | |
==Pseudonyms or Related Conditions== | ==Pseudonyms or Related Conditions== | ||
Latest revision as of 16:59, 2 May 2013
Contents
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
QUALIFIED
Individual at Risk
Recipient
Explanation of Condition
A group of drugs used to treat a number of inflammatory conditions, such as acne or psoriasis.
However, they can cause severe congenital defects if given to pregnant women.
Guidance
Generally unacceptable if ever taken Etretinate (Tigason). Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register.
At CT, inform the transplant centre if a donor is taking these medications, or has done so at any point in the last 12 months.
Pseudonyms or Related Conditions
Version
Version 1, Edition 1
Date of Last Update
15th June 2012
